[Management of cancers of the testis. Results in 61 cases and current trends (author's transl)].
Progress in the management of dysembryoma and choriocarcinoma of the testis has been achieved by more effective chemotherapy (particularly since CDDP was introduced) and by precise timing of surgery, occasional radiotherapy and chemotherapy. In their study, the authors have divided the 61 cancers treated into three stages, depending on whether the lesions were limited to the testis (7 patients with choriocarcinoma and 4 with dysembryoma), had invaded the lymphnodes (16 patients with choriocarcinoma and 9 with dysembryoma) or were disseminated (15 patients with choriocarcinoma and 10 with dysembryoma). The prospects of cure are about 90% for stage 1,75% for stage II and 50% for stage III.
D000293:Adolescent; D000328:Adult; D002822:Choriocarcinoma / Q000188:drug therapy / Q000628:therapy*; D002945:Cisplatin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013724:Teratoma / Q000188:drug therapy / Q000628:therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*
D002945:Cisplatin
Cancers du testicule. Tendances thérapeutiques actuelles. Résultats chez 61 malades.